Today: 12 May 2026
ServiceNow Stock Faces a $30 Billion AI Test as KeyBanc Stays Bearish
11 May 2026
2 mins read

ServiceNow Stock Faces a $30 Billion AI Test as KeyBanc Stays Bearish

NEW YORK, May 11, 2026, 10:02 EDT

ServiceNow’s bold $30 billion AI revenue projection isn’t swaying KeyBanc, which is sticking to its Underweight rating and $85 target price—even after the company told investors it could nearly double subscription revenue by 2030. Analyst Jackson Ader maintained his bearish stance following ServiceNow’s investor day, according to StreetInsider.

The split’s drawing attention as ServiceNow shares, trading under ticker NOW, work to bounce back after a steep drop—investors are watching closely to see if AI gives enterprise software a boost or chips away at SaaS as we know it. Early Monday, ServiceNow was at $93.13, up 2.1%. Market cap: right around $97.1 billion.

KeyBanc’s concerns go beyond just the 2030 target. The firm calculated organic current bookings growth at ServiceNow hit 9.6% for the first quarter—marking the first single-digit print since late 2024. Looking ahead, KeyBanc sees growth dipping to 5.4% in the second quarter, though they predict a rebound to around 20% in the back half. Bookings, which reflect signed customer commitments, serve as a key indicator for future software revenue.

ServiceNow isn’t backing down on its ambitions. During its Financial Analyst Day in Las Vegas on May 4, executives rolled out a bold goal: more than $30 billion in subscription revenue by 2030. They also told analysts that ServiceNow AI could drive over 30% of annual contract value, or ACV—the metric for anticipated yearly contract sales.

Chief Financial Officer Gina Mastantuono didn’t call it a stretch just for effect. “It’s not a blue-sky scenario,” she told Fortune. Mastantuono pointed out ServiceNow was already tracking ahead of its 2021 five-year target by organic measures. Fortune

Signals for the near term are tough to read. ServiceNow posted a 22% jump in first-quarter subscription revenue, hitting $3.67 billion. Contract revenue set to be recognized over the next year climbed to $12.64 billion, up 22.5%. Total remaining performance obligations landed at $27.7 billion.

AI’s making the difference here. ServiceNow’s Now Assist hit $750 million in ACV in the first quarter of 2026, up from $600 million in 2025, and the company projects that figure will cross $1.5 billion before year-end, according to Business Insider. ServiceNow added that AI reasoning costs make up less than 10% of its cost to serve, a key reason gross margins have stayed north of 80% even as usage increases.

This isn’t just about a single chatbot. During Knowledge 2026, ServiceNow rolled out Otto—the company’s new enterprise AI experience—and Action Fabric. With Action Fabric, outside AI agents like Anthropic’s Claude or Microsoft Copilot can trigger governed actions directly on the ServiceNow platform. CEO Bill McDermott summed it up: “AI thinks and workflows act.” ServiceNow

ServiceNow tightened its partnerships with Microsoft and Nvidia. The Microsoft deal pushes AI Control Tower governance through Microsoft Agent 365. Over on the Nvidia front, the companies are rolling out Project Arc—an early-preview autonomous desktop agent, secured by Nvidia OpenShell and managed by ServiceNow AI Control Tower.

Still, the risk section looms. ServiceNow has pointed to postponed government contracts in the Middle East, and its $7.75 billion deal for Armis is set to squeeze 2026 margins—a hit of about 200 basis points to free cash flow margin is on the table. One basis point equals one-hundredth of a percentage point.

The backdrop remains brutal as Salesforce, Oracle, and Freshworks face scrutiny over whether AI agents are a drag on, or a boost for, their core software businesses. Reuters has pointed to AI tools from Anthropic and others putting pressure on shares of names like Salesforce and ServiceNow. Oracle, for its part, is busy overhauling its Fusion cloud suite, focusing on so-called “agentic apps.” Reuters Reuters

So, KeyBanc’s call doesn’t sit comfortably for ServiceNow. The pitch: investors need to buy into a years-long AI growth narrative. But doubts are lingering—skeptics keep circling questions about bookings, timing on deals, and whether clients will actually cough up more money as software takes over tasks people used to handle. “How things will evolve over the coming three, four, five years and even longer” is the real worry, Madison Investments portfolio manager Joe Maginot told Reuters, weighing in on the broader software dilemma. Reuters

Stock Market Today

  • Wall Street Slides as AI Stocks Falter and Oil Prices Rise Amid Iran Conflict
    May 12, 2026, 5:23 PM EDT. Wall Street paused its record-setting rally as AI stocks declined and oil prices climbed amid tensions with Iran. The S&P 500 dropped 0.2% from its previous high, while the Nasdaq slipped 0.7%. Dow Jones Industrial Average rose slightly by 56 points. Significant losses hit chipmakers: Intel fell 6.8%, Micron Technology 3.6%, trimming strong year-to-date gains. South Korea's Kospi also dropped 2.3%, spooked by potential AI profit redistribution. Brent crude surged 3.4% to $107.77 a barrel due to Strait of Hormuz restrictions from the Iran war. Rising oil costs worsened U.S. inflation, surpassing forecasts, with Treasury yields climbing to 4.45%. Investors anticipate the Federal Reserve may maintain or hike interest rates amid persistent inflation concerns.

Latest article

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

12 May 2026
Tesla shares fell 2.7% to $433.45 after U.S. inflation data pushed Treasury yields higher and Reuters reported long waits and spotty robotaxi service in Texas. The stock swung from a high of $447.56 to a low of $422.39. Tesla’s valuation remains near $1.53 trillion, with a price-to-earnings ratio close to 398. Management cited cautious robotaxi rollout and increased 2026 capital spending above $25 billion.
Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

12 May 2026
Ernexa Therapeutics shares jumped 58.5% to $11.43 Tuesday after renewed investor focus on its preclinical ovarian-cancer therapy ERNA-101, following a May 11 investor event. Trading volume reached about 18.85 million shares. The company reported $8.3 million in cash as of April 30, less than needed for its 12-month plan, and may use an at-the-market stock sale to raise funds.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
GCT Semiconductor Stock Moves Before Q1 Earnings as Satellite 5G Deal Raises Stakes
Previous Story

GCT Semiconductor Stock Moves Before Q1 Earnings as Satellite 5G Deal Raises Stakes

VTI vs ITOT: The 0.03% ETF Choice Investors Are Rechecking as Big Tech Drives the Market
Next Story

VTI vs ITOT: The 0.03% ETF Choice Investors Are Rechecking as Big Tech Drives the Market

Go toTop